Pharmaceutical industry now utilize Nanotechnology as a platform for new technology development. It is the science that deals with the processes that occur at molecular level and of nanolength scale size.
For the past few decades, pharmaceutical companies are investing on modernized ways and methods to find a viable way to get insulin into the bodies of people with diabetes without needles. Naturally the idea of an insulin inhaler, similar to an asthma inhaler, was an appealing prospect.
In the large scale production of medicines quality, is not achieved by accident. It is result of a carefully constructed quality assurance system. This system must ensure that each medicinal product conforms to its intended use.
A defect is an undesirable characteristic of a product. It is defined as a failure to conform to specifications or a unit of a product which contains one or more defects is called a defective.
During the last 2 decades, aseptic processing has advanced with the use of isolators and Restricted Access Barrier Systems (RABS) as a means of detaching the operator from "critical areas" thereby reducing potentials risks in products.
Protecting yourself from highly hazardous materials doesn't have to make you look out of this world.
Blow-fill-seal (BFS) aseptic processing is an advanced technology perceived to be a proficient and safe system in filling and packaging sterile pharmaceutical liquids and other related health products used in ophthalmic and respiratory condition management.
Biodecontamination using hydrogen peroxide (H2O2), a highly effective sterilant being used in the disinfection of packaging materials and in processes where sterilisation is required.